Table 1.

Study population demographic and clinical characteristics

	Adults (n = 11)	Children (n = 20)	Total (n = 31)
Age, years, mean±SD (range)	57.9±15.3 (39.5–91.3)	7.5±5.0 (1.3–19.2)	25.4±26.4 (1.3–91.3)
Female sex, n (%)	6 (54.6)	10 (50.0)	16 (51.6)
Weight, mean ± SD (range)	61.2±10.7 (42.0–79.0)	20.9±13.8 (9.0–65.0)	35.2±23.3 (9.0–79.0)
BMI, mean ± SD (range)	24.2±3.2 (18.7–29.4)	−	−
BMI: 18.5–24.9, n (%)	5 (55.7)	−	−
BMI: 25.0–29.9, n (%)	4 (44.4)	−	−
Time since SBS/CIF diagnosis, years, mean±SD (range)	10.2±5.9 (1.4–22.4)	6.6±4.2 (0.9–18.1)	7.9±5.1 (0.9–22.4)
Disease classification, n (%)
SBS†	5 (45.5)	12 (60.0)	17 (54.8)
Ultra-SBS†	4 (36.4)	8 (40.0)	12 (38.7)
Functional SBS*	2 (18.4)	−	2 (6.5)

SBS/CIF, short-bowel syndrome/chronic intestinal failure; SD, standard deviation.

^†Classification according to 2016 ESPEN definitions: SBS − remnant bowel <200 cm; ultra-SBS − remnant bowel <20 cm for adults and <10 cm for children [9].

^*As defined by Pironi et al. [4].